Cholesterol

The purpose of the study is to determine the effectiveness of an investigational injectable drug compared to a placebo (inactive substance) in patients with high cholesterol. The study will last up to 18 months with up to 10 visits to our office. While in the study, your study-related visits, study-related medication, lab work and procedures are provided at no charge. If you do qualify and enroll, you may be compensated for your time and travel. Please fill out your information below to be contacted about this research study.

If you would like to list further medical details please click here.

The following sections detail various medical conditions. Please tick any of the conditions that you suffer from.

Bones & Joints

Cancer

Chronic Pain

Diabetes

Digestion & Bowel

Ear, nose & throat

Endocrine & metabolism

Eye Health

Heart & circulation

Immunology & Vaccination

Infectious Disease

Mind, mood & memory

Reproduction & womens health

Respiratory

Skin Conditions

Urinary

Preferred Contact Method *

Why take part?

Participants will receive study-related doctor’s care, study medication at no cost. We can also help you transport to and from one of our dedicated clinics.
Millions of people lack the treatment they need to manage their conditions. As one of the largest and most recognized clinical study organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself.

 

Who is Synexus?

Synexus is a company dedicated to conducting clinical studies, and has been investigating the effectiveness of new study drugs and treatments for more than 20 years. We provide a friendly, relaxed environment in our own clinics where you have the chance to help shape the future of health for yourself and for others.
We are sure you probably have more questions about the study, and we would be happy to take the time to give you more details.

 

 

Your feedback is vital to the success of our research. Please fill in the form fields below.